Characteristics | Training cohort | p-value | Validation cohort | p-value | ||
---|---|---|---|---|---|---|
LTET (n = 61) | HTET (n = 59) | LTET (n = 26) | HTET (n = 26) | |||
Sex (%) | ||||||
 Male | 28 (45.90%) | 38 (64.41%) | 0.04 | 11 (42.31%) | 18 (69.23%) | 0.03 |
 Female | 33 (54.10%) | 21 (35.59%) | 15 (57.69%) | 8 (30.77%) | ||
Age (mean ± SD, years) | 56.44 ± 9.48 | 51.76 ± 12.08 | 0.02 | 56.50 ± 8.30 | 54.53 ± 11.02 | 0.04 |
Symptom (%) | ||||||
 + | 25 (40.98%) | 30 (50.85%) | 0.28 | 12 (46.15%) | 16 (61.54%) | 0.57 |
 - | 36 (59.02%) | 29 (49.15%) | 14 (53.85%) | 10 (38.46%) |